Month: August 2016

CRISPR sits in the middle of a costly patent brawl. That hasn’t stopped scientists and venture capitalists from betting on who will win. Business is moving fast with licenses being sold, awaiting the USPTO’s decision in November which may declare a winner on the patent. When...